MedTrace Logo

Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)

NCT03529799 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-06-29

Study results available
· View outcomes & findings →

Summary

This study aims to determine the validity and safety of disparity driven vergence using a portable goggle system (I-PAS) using a pseudorandom ternary sequence of frequencies for testing.

Conditions

  • Mild Traumatic Brain Injury

Interventions

DEVICE

I-PAS Goggles

Portable, head-mounted display goggle system with integrated eye capture technology

Sponsors & Collaborators

  • Neurolign

    collaborator INDUSTRY

  • University of Miami

    lead OTHER

Principal Investigators

  • Michael Hoffer, MD · University of Miami

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-20
Primary Completion
2019-09-25
Completion
2019-09-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03529799 on ClinicalTrials.gov